Details:
Pervistop (Epigallocatechin Gallate) once-daily supplement provides a true alternative to eradicating the root problem of HPV persistence, which can unpredictably evolve into cancer.
Lead Product(s): Green Tea Extract,Hyaluronic Acid,Vitamin B12
Therapeutic Area: Infections and Infectious Diseases Product Name: Pervistop
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 01, 2022
Details:
Under the License Agreement, SciClone will be responsible for conducting and funding local clinical development as well as commercialization of Vaborem® (meropenem). To facilitate patients in China, SciClone will conduct local clinical trials and pursue approvals in China.
Lead Product(s): Meropenem,Vaborbactam
Therapeutic Area: Infections and Infectious Diseases Product Name: Vaborem
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: SciClone
Deal Size: $113.0 million Upfront Cash: Undisclosed
Deal Type: Licensing Agreement September 20, 2022
Details:
Flamma has entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury® supply chain. Flamma will continue to use its sites in Italy and China to support Gilead in supplies of the drug for Covid-19.
Lead Product(s): Remdesivir
Therapeutic Area: Infections and Infectious Diseases Product Name: Veklury
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Gilead Sciences
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 05, 2020